This page contains a Flash digital edition of a book.
Eisenbarth_edit_Cardiology_book_temp 22/12/2009 10:15 Page 84
Type 1 Diabetes
23. Todd JA, Acha-Orbea H, Bell JI, et al., 1988 A molecular 47. Aly TA, Baschal EE, Jahromi MM, Analysis of single euglycemic subjects, Best Pract Res Clin Endocrinol Metab,
basis for MHC class II associated autoimmunity, Science, nucleotide polymorphisms identifies major type 1A 2005;19:101–17.
1988;240:1003–9. diabetes locus telomeric of the major histocompatibility 71. Achenbach P, Koczwara K, Knopff A, et al., Mature high-
24. Rewers M, Bugawan TL, Norris JM, Newborn screening for complex, Diabetes, 2008;57:770–76. affinity immune responses to (pro)insulin anticipate the
HLA markers associated with IDDM: diabetes autoimmunity 48. Baschal EE, Eisenbarth GS, Extreme genetic risk for type 1A autoimmune cascade that leads to type 1 diabetes, J Clin
study in the young (DAISY), Diabetol, 1996;39:807–12. diabetes in the post-genome era, J Autoimmun, 2008;31:1–6. Invest, 2004;114:589–97.
25. She J-X, Susceptibility to type I diabetes: HLA-DQ and DR 49. Noble JA, Valdes AM, Bugawan TL, et al., The HLA class I A 72. Yu L, Eisenbarth GS, Humoral autoimmunity in type 1
revisited, Immunol Today, 1996;17:323–9. locus affects susceptibility to type 1 diabetes, Human diabetes: cellular, molecular and clinical immunology. In:
26. Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T, Immunol, 2002;63:657–64. Eisenbarth GS (ed.), Type I Diabetes: Molecular, Cellular and
Concordance for islet autoimmunity among monozygotic 50. Nejentsev S, Howson JM, Walker NM, et al., Localization of Clinical Immunology, 2009. Available at: www.uchsc.edu/
twins, N Engl J Med, 2008;359:2849–50. type 1 diabetes susceptibility to the MHC class I genes misc/diabetes/books.html
27. Redondo MJ, Fain PR, Krischer JP, et al., Expression of beta- HLA-B and HLA-A, Nature, 2007;450:887–92. 73. Yu L, Robles DT, Abiru N, et al., Early expression of
cell autoimmunity does not differ between potential 51. Valdes AM, Erlich HA, Noble JA, Human leukocyte antigen antiinsulin autoantibodies of humans and the NOD mouse:
dizygotic twins and siblings of patients with type 1 class I B and C loci contribute to Type 1 Diabetes (T1D) evidence for early determination of subsequent diabetes,
diabetes, J Autoimmun, 2004;23:275–9. susceptibility and age at T1D onset, Hum Immunol, Proc Natl Acad Sci U S A, 2000;97:1701–6.
28. Furukawa N, Miyamura N, Nishida K, et al., Possible 2005;66:301–13. 74. Vardi P, Ziegler AG, Matthews JH, et al., Concentration of
relevance of alpha lipoic acid contained in a health 52. Alper CA, Larsen CE, Dubey DP, The haplotype structure of insulin autoantibodies at onset of type I diabetes. Inverse
supplement in a case of insulin autoimmune syndrome, the human major histocompatibility complex, Hum Immunol, log-linear correlation with age, Diab Care, 1998;11:736–9.
Diabetes Res Clin Pract, 2007;75:366–7. 2006;67:73–84. 75. Verge CF, Gianani R, Kawasaki E, et al., Prediction of type I
29. Graves PM, Rotbart HA, Nix WA, et al., Prospective study of 53. Bilbao JR, Calvo B, Aransay AM, et al., Conserved extended diabetes in first-degree relatives using a combination of
enteroviral infections and development of beta-cell haplotypes discriminate HLA-DR3-homozygous Basque insulin, GAD, and ICA512bdc/IA-2 autoantibodies, Diabetes,
autoimmunity. Diabetes AutoImmunity Study in the Young patients with type 1 diabetes mellitus and celiac disease, 1996;45:926–33.
(DAISY), Diabetes Res Clin Pract, 2003;59:51–61. Genes Immun, 2006;7:550–54. 76. Bingley PJ, Christie MR, Bonifacio E, et al., Combined analysis
30. Norris JM, Yin X, Lamb MM, et al., Omega-3 54. Baschal EE, Aly TA, Jasinski JM, et al., The frequent and of autoantibodies improves prediction of IDDM in islet cell
polyunsaturated fatty acid intake and islet autoimmunity in conserved DR3-B8-A1 extended haplotype confers less antibody-positive relatives, Diabetes, 1994;43:1304–10.
children at increased risk for type 1 diabetes, JAMA, diabetes risk than other DR3 haplotypes, Diabetes Obes 77. Baschal EE, Aly TA, Babu SR, et al., HLA-DPB1*0402
2007;298:1420–28. Metab, 2009;11(Suppl. 1):25–30. Protects Against Type 1A Diabetic Autoimmunity in the
31. Poole JA, Barriga K, Leung DY, et al., Timing of initial 55. Hanahan D, Peripheral-antigen-expressing cells in thymic Highest Risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY
exposure to cereal grains and the risk of wheat allergy, medulla: factors in self-tolerance and autoimmunity, Curr Population, Diabetes, 2007;56:2405–9.
Pediatrics, 2006;117:2175–82. Opin Immunol, 1998;10:656–62. 78. Barker JM, Barriga K, Yu L, et al, Prediction of autoantibody
32. Salminen KK, Vuorinen T, Oikarinen S, et al., Isolation of 56. Chentoufi AA, Polychronakos C, Insulin expression levels in positivity and progression to type 1 diabetes: Diabetes
enterovirus strains from children with preclinical Type 1 the thymus modulate insulin-specific autoreactive T-cell Autoimmunity Study in the Young (DAISY), J Clin Endocrinol
diabetes, Diabet Med, 2004;21:156–64. tolerance, Diabetes, 2002;51:1383–90. Metab, 2004;89:3896–3902.
33. Stene LC, Joner G, Use of cod liver oil during the first year 57. Bottini N, Musumeci L, Alonso A, et al., A functional variant 79. Barker JM, Goehrig SH, Barriga K, et al., Clinical
of life is associated with lower risk of childhood-onset type of lymphoid tyrosine phosphatase is associated with type I characteristics of children diagnosed with type 1 diabetes
1 diabetes: a large, population-based, case-control study, diabetes, Nat Genet, 2004;36:337–8. through intensive screening and follow-up, Diabetes Care,
Am J Clin Nutr, 2003;78:1128–34. 58. Zoledziewska M, Perra C, Orru V, et al., Further evidence of 2004;27:1399–1404.
34. Ziegler AG, Schmid S, Huber D, et al., Early infant feeding a primary, causal association of the PTPN22 620W variant 80. Stene LC, Barriga K, Hoffman M, et al., Normal but
and risk of developing type 1 diabetes-associated with type 1 diabetes, Diabetes, 2008;57:229–34. increasing hemoglobin A1c levels predict progression from
autoantibodies, JAMA, 2003;290:1721–8. 59. Zheng W, She JX, Genetic association between a lymphoid islet autoimmunity to overt type 1 diabetes: Diabetes
35. Hyttinen V, Kaprio J, Kinnunen L, et al., Genetic liability of tyrosine phosphatase (PTPN22) and type 1 diabetes, Autoimmunity Study in the Young (DAISY), Pediatr Diabetes,
type 1 diabetes and the onset age among 22,650 young Diabetes, 2005;54:906–8. 2006;7:247–53.
Finnish twin pairs, Diabetes, 2003;52:1052–5. 60. Lee YH, Rho YH, Choi SJ, et al., The PTPN22 C1858T 81. Ryan EA, Paty BW, Senior PA, et al., Five-year follow-up
36. Eisenbarth GS, Gottlieb PA, Autoimmune polyendocrine functional polymorphism and autoimmune diseases—a after clinical islet transplantation, Diabetes, 2005;54:2060–69.
syndromes, N Engl J Med, 2004;350:2068–79. meta-analysis, Rheumatology (Oxford), 2007;46:49–56. 82. Alejandro R, Barton FB, Hering BJ, Wease S, 2008 update
37. Perheentupa J, Autoimmune polyendocrinopathy– 61. Genome-wide association study of 14,000 cases of seven from the Collaborative Islet Transplant Registry,
candidiasis–ectodermal dystrophy, J Clin Endocrinol Metab, common diseases and 3,000 shared controls, Nature, Transplantation, 2008;86:1783–8.
2006;91:2843–50. 2007;447:661–78. 83. Eisenbarth GS, Srikanta S, Jackson R, et al., Anti-thymocyte
38. Barker JM, Clinical review: type 1 diabetes-associated 62. Concannon P, Erlich HA, Julier C, et al., Type 1 diabetes: globulin and prednisone immunotherapy of recent onset
autoimmunity: natural history, genetic associations, and evidence for susceptibility loci from four genome-wide type I diabetes mellitus, Diabetes Res, 1985;2:271–6.
screening, J Clin Endocrinol Metab, 2006;91:1210–17. linkage scans in 1,435 multiplex families, Diabetes, 84. Assan R, Feutren G, Debray-Sachs M, et al., Metabolic and
39. Park Y, She JX, Wang CY, et al., Common susceptibility and 2005;54:2995–3001. immunological effects of cyclosporine in recently Type I
transmission pattern of human leukocyte antigen DRB1- 63. Ueda H, Howson JM, Esposito L, et al., Association of the diabetes mellitus, Lancet, 1985;1(8420):67–71.
DQB1 haplotypes to Korean and Caucasian patients with T-cell regulatory gene CTLA4 with susceptibility to 85. Sherr J, Sosenko J, Skyler JS, Herold KC, Prevention of type 1
type 1 diabetes, JCEM, 2000;85:4538–42. autoimmune disease, Nature, 2003;423:506–11. diabetes: the time has come, Nat Clin Pract Endocrinol Metab,
40. Erlich H, Valdes AM, Noble J, et al., HLA DR-DQ haplotypes 64. Burton PR, Clayton DG, Cardon LR, et al., Association scan 2008;4:334–43.
and genotypes and type 1 diabetes risk: analysis of the of 14,500 nonsynonymous SNPs in four diseases identifies 86. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL, Suppression
type 1 diabetes genetics consortium families, Diabetes, autoimmunity variants, Nat Genet, 2007;39:1329–37. of diabetes in nonobese diabetic mice by oral administration
2008;57:1084–92. 65. Lowe CE, Cooper JD, Brusko T, et al., Large-scale genetic of porcine insulin, Proc Natl Acad Sci U S A, 1991;88:10252–6.
41. Hattori M, Buse JB, Jackson RA, et al., The NOD mouse: fine mapping and genotype-phenotype associations 87. Bingley PJ, Mahon JL, Gale EA, Insulin resistance and
recessive diabetogenic gene within the major implicate polymorphism in the IL2RA region in type 1 progression to type 1 diabetes in the European
histocompatibility complex, Science, 1986;231:733–5. diabetes, Nat Genet, 2007;39:1074–82. Nicotinamide Diabetes Intervention Trial (ENDIT), Diabetes
42. Kloting I, Schmidt S, Kovacs P, Mapping of novel genes 66. Todd JA, Walker NM, Cooper JD, et al., Robust associations Care, 2008;31:146–50.
predisposing or protecting diabetes development in the of four new chromosome regions from genome-wide 88. Bingley PJ, Gale EA, Progression to type 1 diabetes in islet
BB/OK rat, Biochem Biophys Res Commun, 1998;245:483–6. analyses of type 1 diabetes, Nat Genet, 2007;39:857–64. cell antibody-positive relatives in the European Nicotinamide
43. Wallis RH, Wang K, Marandi L, et al., Type 1 diabetes in the 67. Smyth DJ, Cooper JD, Bailey R, et al., A genome-wide Diabetes Intervention Trial, Diabetologia, 2006;49:881–90.
BB rat: a polygenic disease, Diabetes, 2009;58:1007–17. association study of nonsynonymous SNPs identifies a type 89. Ludvigsson J, Faresjo M, Hjorth M, et al., GAD treatment
44. Aly TA, Ide A, Jahromi MM, et al., Extreme genetic risk for 1 diabetes locus in the interferon-induced helicase (IFIH1) and insulin secretion in recent-onset type 1 diabetes, N Engl
type 1A diabetes, Proc Natl Acad Sci U S A, 2006;103:14074–9. region, Nat Genet, 2006;38:617–19. J Med, 2008;359:1909–20.
45. Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler AG, 68. Concannon P, Rich SS, Nepom GT, Genetics of type 1A 90. Herold KC, Hagopian W, Auger JA, et al., Anti-CD3
IDDM1 and multiple family history of type 1 diabetes diabetes, N Engl J Med, 2009;360:1646–54. monoclonal antibody in new-onset type 1 diabetes
combine to identify neonates at high risk for type 1 69. Achenbach P, Bonifacio E, Williams AJ, et al., Autoantibodies mellitus, N Engl J Med, 2002;346:1692–8.
diabetes, Diabetes Care, 2004;27:2695–2700. to IA-2beta improve diabetes risk assessment in high-risk 91. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al.,
46. Wucherpfennig KW, Eisenbarth GS, Type 1 Diabetes, Nat relatives, Diabetologia, 2008;51:488–92. Insulin needs after CD3-antibody therapy in new-onset type
Immunol, 2001;2:1–3. 70. Achenbach P, Ziegler AG, Diabetes-related antibodies in 1 diabetes, N Engl J Med, 2005;352:2598–2608.
84 US ENDOCRINOLOGY
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124
Produced with Yudu - www.yudu.com